Sponsors and Exhibitors - SynBioBeta SF 2017 SynBioBeta SF 2017

Bronze Sponsors

Agilent Technologies

Agilent Technologies Inc. is a global leader in analytical laboratory technologies. With more than 50 years of insight and innovation, our instruments, software, services, solutions and people provide trusted answers to our customers' most challenging questions. The company generated revenues of $4.20 billion in fiscal 2016 and employs about 13,000 people worldwide. Information about Agilent is available at www.agilent.com.

Amazon Web Services

For 11 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud platform. AWS offers over 90 fully featured services for compute, storage, networking, database, analytics, application services, deployment, management, developer, mobile, Internet of Things (IoT), Artificial Intelligence (AI), security, hybrid, and enterprise applications, from 44 Availability Zones (AZs) across 16 geographic regions in the U.S., Australia, Brazil, Canada, China, Germany, India, Ireland, Japan, Korea, Singapore, and the UK. AWS services are trusted by millions of active customers around the world -- including the fastest growing startups, largest enterprises, and leading government agencies -- to power their infrastructure, make them more agile, and lower costs. To learn more about AWS, visit https://aws.amazon.com.

America’s Seed Fund

America’s Seed Fund is a program within the National Science Foundation. NSF is a federal agency that supports fundamental research and education across all fields of science and engineering, currently with a $7.5 billion budget. Through the merit review process, NSF funds the most innovative ideas in science and technology. Notable NSF-supported advances include Doppler radar, the Internet, web browsers, bar codes, magnetic resonance imaging, inkjet printers, computer-aided design systems, tissue engineering, and other technology-based innovations that spur economic activity and improve the quality of life for all Americans.

BGI Genomics

BGI Genomics is a part of BGI Group, one of the world’s largest genomics organizations. BGI Group was founded in 1999 with the vision of using genomics to benefit humanity and has since become the largest genomic organization in the world. With a focus on research and applications in the healthcare, agriculture, conservation, and environmental fields, BGI Group has a proven track record of innovative, high profile research, which has generated over 2,000 publications. BGI Genomics provides a wide range of commercial next generation sequencing services and a broad portfolio of genetic tests for medical institutions, research institutions and other public and private partners. BGI Genomics’ mission is to leverage its genomics expertise in order to advance life science research and to improve human health by providing high quality, affordable genomics powered health solutions that are available for everybody. BGI Genomics has particular strengths in prenatal screening, hereditary cancer screening, testing for rare disease and in aiding precision medicine research. Numerous scientific partners, healthcare providers and pharmaceutical companies have come to rely on BGI Genomics’ world leading bio-informatics research and development, large scale computing infrastructure and proprietary sequencing platforms. BGI Genomics is headquartered in Shenzhen, China, with branches and medical laboratories in major cities including Beijing, Tianjin, Wuhan, Shanghai and Guangzhou. BGI Genomics also has offices and laboratories located in Europe, North America and the Asia Pacific region.

Data Collective - DCVC

Data Collective (DCVC) is a venture capital fund that backs entrepreneurs applying deep tech to transform giant industries. DCVC and its principals have supported brilliant people changing global-scale businesses for over twenty years, helping create tens of billions of dollars of wealth while also making the world a markedly better place.

DCVC brings to bear a unique model that unites a team of experienced venture capitalists with more than 50 technology executives and experts (CTOs, CIOs, Chief Scientists, Principal Engineers, Professors at Stanford, Berkeley, and major technical universities) with significant tenures at top 100 technology companies and research institutions worldwide.

DCVC focuses on Seed and Series A companies, and growth stage opportunities within its own portfolio.

DCVC’s strong network, operational experience and technical background delivers unique value to entrepreneurs. We still read code. We understand chip architecture and when to run BLAST versus Bowtie. We've built supercompute racks ourselves, and we know that degrees of freedom doesn’t mean how often a robot escapes. We know that PyTorch isn’t something you use to make crème brulee. And we will be there at 3 am to cheer the new build or at 7 am to help land that new customer.

DuPont

DuPont has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials and services since 1802. The company believes that by collaborating with customers, governments, NGOs and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit www.dupont.com.

GenScript

GenScript is the world leader in gene synthesis, and a peptide, protein, and antibody research partner for fundamental life science research, translational biomedical research, early stage biopharmaceutical development, and synthetic biology. Since its founding in 2002, GenScript has provided services and products to scientists in more than 100 countries worldwide. The company delivers biological research services encompassing gene synthesis and molecular biology, peptide synthesis, custom antibodies, protein expression, antibody and protein engineering, in vitro and in vivo pharmacology and industrial synthetic biology products. For more information, visit www.genscript.com.

Integrated DNA Technologies

Integrated DNA Technologies (IDT) is the world leader in delivering custom nucleic acid products for the life sciences market in the areas of academic research, medical diagnostics, biotechnology, agriculture, and pharmaceutical development. The company's primary business is the production of custom oligonucleotides for molecular biology applications. IDT has developed proprietary technologies for genomics applications, such as next generation sequencing, CRISPR genome editing, qPCR, and RNA interference. Through its GMP services, IDT manufactures products used in diagnostic tests for cancer and most inherited and infectious diseases. For more information, visit www.idtdna.com.

M Ventures

We drive innovation and back entrepreneurs through equity investments and hands on support in fields that could impact the vitality and sustainability of our parent’s company (Merck KGaA, Darmstadt, Germany) current and future businesses. We are the strategic, corporate venture capital arm of Merck. Our mandate is to invest in innovative technologies and products with the potential to significantly impact our parent company’s core business areas. From our headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. We take an active role in our portfolio companies and team up with entrepreneurs and co-investors to translate innovation towards commercial success. We have a significant focus on early stage investing and company creation including the creation of spin-offs to leverage Merck’s science and technology base.

Mintz Levin

The development of biologic therapeutics has entered a new age of competition following passage of a biosimilar law in the United States. The law is known as the Biologics Competition and Innovation Act, or "BPCIA." To give your company the best advantage in this market you need advice and counsel from professionals who know your industry. Professionals who give straightforward strategic and legal advice founded in real world experience. That’s the Mintz Levin team. Mintz Levin has built up a world class reputation in the Life Sciences space, with significant emphasis on biotechnology. Our attorneys understand the playing field and the players in the biologics and biosimilars space. We know and have navigated our clients through the complicated pathways to success through which your company and products must pass – FDA regulatory, transactional, and innovation protection.

Molecular Assemblies

Molecular Assemblies, Inc. is a San Diego-based company focused on developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company’s patented enzymatic method, based on making DNA the way nature makes DNA, produces long, high quality, sequence-specific DNA reliably, affordably and sustainably. Molecular Assemblies’ technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines and bio-based electronics. For more information please visit molecularassemblies.com.

Synthetic Genomics

Synthetic Genomics is programming the operating system of life to create sustainable solutions for humankind’s most pressing issues, from the wellbeing of our population to the health of our planet. With an unmatched understanding of how DNA drives the function of cells — the basic biological units of all living organisms — Synthetic Genomics modifies and writes genomes to enable transformative products in the areas of vaccines, medicines, nutrition, and biotechnology research. In addition to designing novel organisms that overcome fundamental hurdles of scientific research and medicine, Synthetic Genomics pursues partnerships with organizations seeking to dramatically improve upon existing products in energy, health care and other sectors. Continuing its legacy of scientific firsts in genomics and synthetic biology, Synthetic Genomics is harnessing the power of nature to improve quality of life. More information is available at syntheticgenomics.com.

Exhibitors

Analytik Jena

Analytik Jena is a provider of instruments and products in the areas of analytical measuring technology and life science. Its portfolio includes the most modern analytical technology and complete systems for bioanalytical applications in the life science area. Comprehensive laboratory software management and information systems (LIMS), service offerings, as well as device-specific consumables and disposables, such as reagents or plastic articles, complete the Group’s extensive range of products.

Agilent Technologies

Amazon Web Services

America’s Seed Fund

Bell Biosystems

Bell Biosystems is a privately-held cell therapy biotools company focused on commercializing its Magnelle^(R)cell labeling and tracking platform, and was recognized in 2014 by the Obama White House OSTP as one of five recipients for Exemplary Life Science Platform Technologies award. The company has assembled a strong patent portfolio, and has been funded by a world-class list of early investors and multiple grants from the National Institutes of Health. Bell Biosystems is headquartered in the Johnson & Johnson Innovations Lab Qb3 in the San Francisco Bay Area.

Berkeley Lab

Berkeley Lab is a member of the national laboratory system supported by the U.S. Department of Energy through its Office of Science. It is managed by the University of California (UC) and is charged with conducting unclassified research across a wide range of scientific disciplines. Located on a 202-acre site in the hills above the UC Berkeley campus that offers spectacular views of the San Francisco Bay, Berkeley Lab employs approximately 3,232 scientists, engineers and support staff. The Lab’s total costs for FY 2014 were $785 million. A recent study estimates the Laboratory’s overall economic impact through direct, indirect and induced spending on the nine counties that make up the San Francisco Bay Area to be nearly $700 million annually. The Lab was also responsible for creating 5,600 jobs locally and 12,000 nationally. The overall economic impact on the national economy is estimated at $1.6 billion a year. Technologies developed at Berkeley Lab have generated billions of dollars in revenues, and thousands of jobs. Savings as a result of Berkeley Lab developments in lighting and windows, and other energy-efficient technologies, have also been in the billions of dollars.

BGI Genomics

CustomArray

CustomArray, Inc. is a provider of oligo pools to many of the world's leading academic and industrial organizations for applications including targeted sequencing, complex DNA libraries, synthetic biology, shRNA libraries, CRISPR, etc. We synthesize DNA electrochemically on arrays of electrodes and then cleave the DNA off to create oligo pools. We have two platforms: arrays with 12,000 electrodes (allowing creation of 12,000 different oligos per array) and arrays with 90,000 electrodes (allowing creation of 90,000 different oligos per array). The advantage of this process is that it can produce libraries of DNA at extremely low price per base (as low as 0.04 cents per base -- see pricing here). Improvements over the past nearly two decades now allow us to create up to 200 mers with average error rates typically around 1 error per 150 bases to 1 per 200 bases. We also sell DNA arrays and related products suitable for the usual assortment of DNA-array applications (gene expression, genotyping, etc.), including an inexpensive, accurate, hand-held-sized DNA-array reader.

DuPont

Elemental Machines

Elemental Machines is revolutionizing science-based industries with powerful insights that help customers transform laboratory operations, research and development processes, and manufacturing outcomes. The Elemental Machines Sensory Network™ monitors and analyzes critical laboratory and production equipment, as well as invisible environmental variables, to provide new levels of clarity, transparency and consistency, and improve repeatability. For more information, visit http://elementalmachines.io.

Fathom

The FATHOM team is driven by advanced technologies that enhance and accelerate our customers’ product development process. Our team is changing the way products are being designed and manufactured by helping designers and engineers make the unmakeable. Industry-leading companies across the country leverage our 3D printing expertise to put satellites into orbit, electric cars on freeways, and a full spectrum of devices into people’s hands and homes. How do we do it? The FATHOM team is uniquely blending additive technologies and materials with foundational manufacturing methods so companies can go from concept to prototype to manufacturing in a way that wasn’t previously possible.

Gene Universal

Gene Universal, located in Delaware USA, is a pioneer in the field of gene synthesis and synthetic biology. As a leading company in genomics research and applied biological technology, and with our strong technical force, unparalleled customized service and fast delivery time, we are aiming to provide more cost-effective service and product to accelerate the global research in drug discovery, biology optimization, food and agriculture, etc. Gene Universal is specialized in the area of genetic engineering, biosystem engineering and synthetic biology. By providing our industrialized and highly intensive gene synthesis platform, we could deliver both normal and complex genes in short promised time. We have also developed sophisticated software programs to design and optimize complex gene libraries and genetic systems, with these bioinformatics tools and our high-efficiency production management systems, we are able to satisfy scientific researchers with high-efficient, low-cost, and large-scale synthetic genes and genome DNA. Meanwhile, based on our five cutting-edge expression systems: Bacterial Expression, Mammalian Expression(293 & CHO), Yeast Expression, Insect Expression and Bacillus subtilis Expression system, we have become the one-stop vendor for your gene synthesis, protein expression, and antibody production services. Our goal is to become the global leader in DNA synthesis and synthetic area, and to achieve the prosperous prospects of making research in life science more efficient and lower cost.

GENEWIZ

GENEWIZ is a global leader in genomics services that enable research scientists within pharmaceutical, biotechnology, agriculture, environmental and clean energy, academic, and government institutions to advance their discoveries. Customers rely on our unique and proprietary genomics technologies and services, backed by our specialized experts in DNA sequencing, gene synthesis, molecular biology, high throughput sequencing, bioinformatics, and GLP regulatory-compliant services. Headquartered in South Plainfield, NJ, GENEWIZ is privately-held with a global network of laboratories in Boston, MA; Washington, D.C. Metro; Research Triangle Park, NC; San Diego, CA; Los Angeles, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, Suzhou, and Tianjin, China; Takeley, United Kingdom; and Tokyo, Japan. For more information, visit www.genewiz.com, and connect with us on LinkedIn, Twitter, Facebook, YouTube, WeChat, and Weibo.

GenScript

Gilson

Gilson is a family-owned global manufacturer of liquid handling, purification and extraction solutions for the life sciences industry. We help researchers advance the pace of discovery by creating easy-to-use lab instruments that improve reproducibility and traceability. Since 1957, we’ve been developing innovative products such as PIPETMAN®. By partnering closely with the scientific community, we’re continuously advancing our product offerings and have added automated pipetting systems and software to our portfolio. Backed by worldwide R&D, service, and support, Gilson strives to enable verifiable science and make lab life easier for our customers.

Hamilton Company

Hamilton Company specializes in the development, manufacturing and customization of precision measurement devices, automated liquid handling workstations, and sample management systems. Hamilton's processes are optimized for quality and flexibility. Whether it's a custom needle with a quick delivery time frame, a special length pH sensor, or a comprehensive solution to fully automate your assay workflow, trust that Hamilton products will always meet your needs. Hamilton Company has been a leading global manufacturer for more than 60 years, with headquarters in Reno, Nevada; Franklin, Massachusetts; Timișoara, Romania; and Bonaduz, Switzerland; and subsidiary offices throughout the world.

iGEM

The iGEM Competition is the premiere student team competition in Synthetic Biology.. For over 10 years, iGEM has been encouraging students to work together to solve real-world challenges by building genetically engineered biological systems with standard, interchangeable parts. Student teams design, build and test their projects over the summer and gather to present their work and compete at the annual Jamboree. Participation in iGEM empowers teams to manage their own projects, advocate for their research and secure funding. Teams are also challenged to actively consider and address the safety, security and environmental implications of their work. Visit the iGEM 2017 Competition page to learn more.

Integrated DNA Technologies

Integrated Project Management

Integrated Project Management Company, Inc. (IPM) is a leading project management consulting firm focused on planning and implementing strategically critical projects in the life sciences, healthcare, consumer products, and industrial sectors. Often working in highly regulated industries, IPM tackles complex projects through dedicated on-site leadership. The IPM leadership approach combines its clients’ internal capabilities and legacy knowledge with its proven ability to inspire stakeholder engagement and buy-in, and to achieve project objectives. Since its inception in 1988, IPM has served more than 350 clients and completed nearly 4,000 projects. Headquartered in Chicago, IPM has regional offices in Boston, St. Louis, Los Angeles, San Francisco, Minneapolis - St. Paul, and New Jersey. In 2016, IPM was recognized as one of Forbes magazine’s 25 Best Small Companies in America. In addition, IPM has been named to Inc. Magazine’s list of 5,000 fastest-growing private companies for seven consecutive years and has been named a “Best Workplace” for seven consecutive years (2010-2016) by the Great Place to Work Institute®. To learn more about IPM and its services, visit www.ipmcinc.com/services or call 630-789-8600.

Intrexon

Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA^™ to create biologically-based products that improve the quality of life and the health of the planet. The Company’s integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA^®, and we invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook, and LinkedIn.

Labcyte

Labcyte, a global biotechnology tools company headquartered in San Jose, California, is revolutionizing liquid handling. Echo® liquid handling systems use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical and biotechnology industries, as well as by hospitals, service laboratories, contract research organizations, and academic institutions. Our customers work across a wide spectrum of scientific research, including drug discovery, genomics, proteomics, diagnostics and personalized medicine. Labcyte has 60 U.S. patents and others internationally. For more information, visit www.labcyte.com. For more information, visit www.labcyte.com.

Lucigen Corporation is working to improve people’s lives by providing quality products and services to life science and healthcare professionals. Founded in Wisconsin in 1998, Lucigen offers products and services that enable life-science professionals to perform their research and testing more efficiently and effectively. The company has grown to manufacture and sell over 130 biomedical research products and services to customers worldwide, all under an ISO 13485 compliant quality system. Core competencies include enzyme evolution, protein expression, cloning, competent cells, next gen sequencing, and molecular diagnostics.

MYcroarray

MYcroarray is a scientist-owned and operated company specializing in the manufacture of custom oligonucleotide libraries and solutions for synthetic biology. We routinely collaborate with our customers and research partners to develop innovative designs and applications for custom synthetic biology project. If you have a new research application, we would welcome the chance to help advance your research with our technology.

New England Biolabs

Established in the mid 1970s, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR and qPCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and seven subsidiaries located in Canada, China, France, Germany, Japan, Singapore and the UK. For more information about New England Biolabs visit www.neb.com.

Opentrons

Today, biologists spend too much time pipetting by hand. We think biologists should have robots to do pipetting for them. People doing science should be free of tedious benchwork and repetitive stress injuries. They should be able to spend their time designing experiments and analyzing data. That's why we started Opentrons. We make robots for biologists. Our mission is to provide the scientific community with a common platform to easily share protocols and reproduce each other's results. Our robots automate experiments that would otherwise be done by hand, allowing our community to spend more time pursuing answers to some of the 21st century’s most important questions.

SGI-DNA

SGI-DNA, a wholly owned subsidiary of Synthetic Genomics Inc., provides genomic solutions to advance scientific discovery. SGI-DNA’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. SGI-DNA’s genomic services include whole genome sequencing, DNA synthesis, library design, bioinformatics, cell engineering, and plasmid DNA cloning and purification. SGI-DNA’s reagents include a complete suite of Gibson Assembly® and Site Directed Mutagenesis kits as well as optimized cell lines. To further enable the synthetic biology workflow, SGI-DNA offers the BioXp™ 3200 System. This fully automated genomics workstation allows the creation of double-stranded DNA fragments, automated cloning, as well as Next-Generation Sequencing DNA library preparation. Building on scientific breakthroughs from J. Craig Venter, Hamilton Smith, Clyde Hutchison, Daniel Gibson and their teams, SGI-DNA is committed to reducing barriers associated with synthetic biology. More information is available at www.sgidna.com.

Synbio Technologies

Synbio Technologies is a DNA technology company founded in 2013 with one idea in mind: to take gene synthesis and synthetic biology into the next generation. This goal was accomplished through the establishment and implementation of our Syno^®Synthesis Platforms. The Syno^®Synthesis Platforms are comprised of three subplatforms (Syno^®1.0, Syno^®2.0 and Syno^®3.0), to deliver high quality DNA and gene synthesis products to our customers. The Syno^®Synthesis Platforms are the foundation for Synbio Technologies’ world leading Genotype-Phenotype-Synotype (GPS) Platform. The GPS Platform combines the analysis of both genetic sequences (Genotype) and biological functions (Phenotype) with the ability to synthesize (Synotype) genes, pathways, and even genomes.It is this platform that Synbio Technologies has integrated into the synthetic biology services we offer our customers.

Synthego

Founded by former SpaceX engineers, Synthego is a leading provider of genome engineering solutions. The company’s flagship product, CRISPRevolution, is a portfolio of synthetic RNA designed for CRISPR genome editing and research. Synthego’s vision is to bring precision and automation to genome engineering, enabling rapid and cost-effective research with consistent results for every scientist. Headquartered in Silicon Valley, California, Synthego customers include leading institutions around the world including countries such as Australia, Belgium, Germany, UK, USA and Switzerland.

Synthetic Genomics

TAXA

The TAXA platform has been specifically designed to enable anyone to perform metabolic engineering of plants without stepping into a lab. We provide access to protein engineering, DNA assembly, transient experiments and stable transformation as a service. The best thing is that anything "Powered by TAXA" is designed to be free from expensive regulatory approval, meaning the products are available for sale or distribution to consumers in the United States immediately after they are developed. For a detailed list of the experiments which can be run on our platform please see the Services page.

TeselaGen

TeselaGen builds secure enterprise quality software platforms for designing, building and precision editing DNA, enabling the development of vaccines, biologic medicines, and sustainably sourced chemicals. TeselaGen is privately held and is based in the software hub of San Francisco, CA. The company has received early recognition in the form of four US National Science Foundation funding awards, a US Department of Energy funding award and a Bio-IT World Best Practices Award. TeselaGen uses its proprietary Synthetic Evolution® technology for efficient rapid prototyping and editing of recombinant molecules. Follow TeselaGen on Facebook, Twitter, LinkedIn, and Google+, and learn more at teselagen.com.

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

TTP Labtech

TTP Labtech designs and manufactures robust, reliable and easy-to-use solutions for sample management, liquid handling and multiplexed detection in drug discovery and genomics. We enable life scientists, through collaboration, deep application knowledge and leading engineering, to accelerate research and make a difference together. Our essential tools include state-of-the-art solutions developed for high throughput compound and biologics screening (acumen^® Cellista, mirrorball^® and fully validated consumables such as sol-R™ beads and plates),flexible sample management workflows from ambient to -80⁰C (comPOUND^®, arktic^®, lab2lab), and unique low-volume liquid handling for genomics, compound screening and protein crystallography (mosquito^® X1, mosquito^® HTS, mosquito^® crystal, mosquito^® LCP, mosquito^® HV, dragonfly^® crystal and dragonfly^®discovery and a full range of validated consumables such as tips and plates).

Twist Bioscience

At Twist Bioscience, our expertise is accelerating science and innovation by leveraging the power of scale. We have developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a high throughput silicon platform capable of producing synthetic biology tools, including genes, oligonucleotide pools and variant libraries. By synthesizing DNA on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic DNA production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production, which in turn, expedites the design, build and test cycle to enable personalized medicines, pharmaceuticals, sustainable chemical production, improved agriculture production, diagnostics and biodetection. We are also developing new technologies to address large scale data storage. For more information, please visit http://www.twistbioscience.com. Twist Bioscience is on Twitter. Sign up to follow our Twitter feed @TwistBioscience at https://twitter.com/TwistBioscience.

Gold Sponsors

Silver Sponsors

Bronze Sponsors

Exhibitors